Malaysia
Search
Sign In
Multidisciplinary
Top Medical News
Nearly one in three children with chronic hepatitis B (CHB) who discontinued their antiviral treatment has relapsed, a study has shown.
A recent study has identified 163 items of skills and knowledge that are necessary as a minimum standard for clinical practice for physiotherapists working in the intensive care unit (ICU) in Singapore.
There appears to be an increased risk of hair loss – a phenomenon called telogen effluvium – after COVID-19 infection.
Individuals who undergo Roux-en-Y gastric bypass (RYGB) show improved high-density lipoprotein (HDL) functionality, which then contributes to a decrease in adipose tissue and systemic inflammation, reports a recent study.
In infants with congenital heart disease (CHD), the perioperative clinical course and socioeconomic status (SES) appear to be better predictors of long-term neurodevelopmental outcomes than conventional neonatal brain magnetic resonance imaging (MRI), a new study has found.
In patients with chronic dependence on oral corticosteroids (OCS) for severe asthma, long-term exposure to dupilumab supports sustained reduction in OCS dosage and improvement in clinical outcomes for up to 96 weeks, according to an analysis of the phase III LIBERTY ASTHMA TRAVERSE study.
Patients with nonalcoholic fatty liver disease (NAFLD) who take probiotics, prebiotics, or synbiotics (PPS) may have better energy metabolism, according to a recent study.
Special Reports
In this third interview of a series focused on dengue, Dr Ravindran Thayan, Head of Virology Unit at Institute for Medical Research, discussed the reasons for epidemic outbreaks in Malaysia, and the challenges associated with dengue surveillance and dengue serotypes in Malaysia.
Dry eye disease (DED) is a multifactorial condition characterized by tear film instability, and results in ocular discomfort and visual disturbance, and may impact patient’s quality of life such as reading and driving at night. The outer most lipid layer of the tear film, formed by the meibum, helps to maintain tear film stability by reducing the rate of tear evaporation. Alteration in the tear lipid layer, because of impaired quality or quantity of the meibum, is one of the most common causes of evaporative DED.
The recent Myeloproliferative Neoplasms Expert Forum: Deep Dive into ERNEST saw Professor Alessandro M. Vannucchi, professor of hematology at the University of Florence, Italy, present an analysis on the ERNEST registry and study, and the subsequent updated ERNEST study. He delved into the patient cohort, benefits in overall survival and symptoms, and answered the perennial question of whether Jakavi® (ruxolitinib) provides absolute improvements in myelofibrosis (MF) survival.
The prevalence of OA, which is the most common cause of disability in the aged population, is increasing in Malaysia owing to a combination of risk factors such as older age and obesity. A COPCORD study conducted in Malaysia found that 64.8% of all joint-related complaints were knee related; among patients assessed for knee pain, over half showed clinical evidence of OA. While the 2013 Malaysian CPG on the Management of Osteoarthritis recommends a linear step-up approach in managing knee OA, monotherapy is often inadequate in relieving pain symptoms and functional limitations experienced by patients with arthritis.
In a virtual lecture series sponsored by Viatris, Dr Dolores Bonzon spoke about the importance of blood pressure (BP) control and recommendations for pharmacologic treatment in the management of paediatric hypertension (HTN). She also discussed the diagnosis and treatment of a paediatric patient with HTN from her practice.
At the recent regional Myeloproliferative Neoplasm (MPN): New Horizons, A Cross-Country Webinar supported by Novartis, Dr Francesco Passamonti, professor of haematology, University Hospital Ospedale di Circolo, Fondazione Macchi, Varese, Italy, addressed the current landscape of treatment surrounding Myelofibrosis (MF) and improving survival outcomes.
3.9 million Malaysians have diabetes, representing a staggering 1in 5 adults. We also have the highest rate of diabetes in Asia and to compound matters, more than half of them will develop chronic kidney disease (CKD) during their lifetime. The incidence of CKD is also rising relentlessly year after year, evolving rapidly into not only a Malaysian, but a global non-communicable disease pandemic. Progressive CKD may not only lead to end-stage renal disease but markedly increases mortality risks, where this grows more than ten times fold if one happens to have CKD.
Conference Reports
Diagnosis, progression, or death due to prostate cancer occur at approximately a decade to 15 years following an initial assessment of prostate-specific antigen (PSA) levels in older men, according to a study presented at EAU 2022.
Studies presented at AAIC 2022 show that dancing could be a protective factor against the development of Alzheimer’s disease (AD) and dementia in older adults.
A large global study of patients with severe COVID-19 admitted to the intensive care unit (ICU) has shown a 14 percent prevalence of haemorrhagic, coagulopathic, and thrombotic (HECTOR) complications in these patients, with mortality risk increased in those with haemorrhagic complications.
Incident tuberculosis (TB) appears to be a risk factor for virologic non-suppression (ie, viral load of >1,000 copies/mL) in HIV patients who have transitioned to dolutegravir (DTG)-based therapy with recycled NRTIs*, according to a retrospective subanalysis of the VISEND study.
A large systematic review and meta-analysis of women undergoing assisted reproduction has shown that the use of short gonadotropin-releasing hormone (GnRH) antagonist protocols, compared with long GnRH agonist protocols, during controlled ovarian stimulation (COS) may reduce the risk of ovarian hyperstimulation syndrome (OHSS) while having no major impact on live birth rates.
Post hoc data from a phase II study presented at AAIC 2022 continue to demonstrate the potential of masupirdine (SUVN-502), a selective 5-HT6 receptor antagonist, as a treatment alternative for the management of neuropsychiatric and cognitive symptoms of Alzheimer’s disease (AD).
Intensive care unit (ICU) hospitalization doubles the risk of subsequent dementia in older adults, a longitudinal study suggests.
Multimedia
